Neumora Therapeutics, Inc.
NMRANeumora Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing next-generation therapies for complex brain diseases.
$307.57M-8.6%
Table of contents
Earnings
Next report
Aug 5, 2026 (In 1 week)EPS estimate-$0.23
Competitors
By market cap
Profile
Neumora Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing next-generation therapies for complex brain diseases. The company integrates a pipeline of novel, brain-penetrant drug candidates with a proprietary precision neuroscience platform to improve treatment outcomes for neuropsychiatric and neurodegenerative disorders.
Competitive position
A clinical-stage innovator utilizing a precision medicine approach to differentiate its pipeline from standard-of-care treatments in neuropsychiatry and neurodegeneration.
GeographiesUnited States, Global
Customer segmentsPatients, Healthcare providers
Business modelR&D intensive, IP licensing
SuppliersContract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic research institutions, Raw material suppliers
CustomersPharmaceutical distributors, Hospitals, Specialty pharmacies, Third-party payors
CountryUnited States of America
Listed2023
Employees120.0
CEOPaul L. Berns
SectorHealthcare
IndustryBiotechnology
Websiteneumoratx.com
FilingsSEC EDGAR
Questions, answered.
- What is Neumora Therapeutics, Inc.'s market cap?
- Neumora Therapeutics, Inc. (NMRA) has a market capitalization of $307.6M and trades on NASDAQ.
- Who are Neumora Therapeutics, Inc.'s competitors?
- Neumora Therapeutics, Inc.'s key competitors include Xenon Pharmaceuticals, Neurocrine Biosciences, Axsome Therapeutics, and others. These companies compete in similar markets and product categories.
- Who does Neumora Therapeutics, Inc. partner with?
- Neumora Therapeutics, Inc.'s notable partners include Amgen, Vanderbilt University, The Scripps Research Institute, and others.
- What subsidiaries does Neumora Therapeutics, Inc. have?
- Neumora Therapeutics, Inc.'s subsidiaries include BlackThorn Therapeutics.
- Where is Neumora Therapeutics, Inc. headquartered?
- Neumora Therapeutics, Inc. is headquartered in United States of America and employs approximately 120 people. It has been publicly traded since 2023.